Le Lézard
Classified in: Health
Subject: HEALTH

Brain Cancer Canada Matches Community Fundraising to Support Groundbreaking DIPG Research


TORONTO, May 17, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), a leading advocate in the fight against brain cancers, is proud to announce a $100,000 research grant awarded to Dr. James T. Rutka, Paediatric Neurosurgeon, and his team at The Hospital for Sick Children.

Dr. Rutka's research project targets childhood Diffuse Intrinsic Pontine Glioma (DIPG), a highly aggressive tumour that currently has no effective treatments.

The grant starts with an incredible $50,000 raised by the tireless DIPG community, an amount matched by BCC to support this critical research further.

"DIPG is a devastating disease, taking the lives of our precious children far too soon. The loss for patients and their families is immeasurable, and it touches us deeply," said Angela Scalisi, Chair of BCC. "From a broader perspective, DIPG also has one of the highest societal burdens of any disease."

Dr. Rutka's early-stage research proposes a novel approach to addressing DIPG. His team will investigate the potential of magnetic resonance-guided focused ultrasound (MRgFUS) to improve the delivery of therapeutics across the blood-brain barrier, a significant challenge in treating brain tumours.

"The primary aim of our research is to explore innovative methods to deliver therapeutics more effectively to DIPGs," Dr. Rutka said. "We are excited that our encouraging pre-clinical studies on DIPG have now been translated into the ?first in human' clinical trial for children with this otherwise fatal brain-stem tumour. By combining MRgFUS with patient-specific biologicals, we hope to increase the concentration of active compounds within this brain-stem tumour, potentially influencing tumour growth and survival."

The DIPG community ? patients, caregivers, families and friends of patients, and survivors ? has been instrumental in fundraising and raising awareness about this devastating disease.

"We didn't get enough time with our sweet, beautiful Isabelle," said Michal and Jackie Borkowski, parents and active members of the DIPG community. "We can't change what happened to her, but we hope we can help change things for other children fighting DIPG." The Borkowskis lost their 4-year-old daughter, Isabelle, to DIPG in December 2020.

"This community is a pillar of strength and determination," said Marc Peeters, Director of the Board of Partnerships and Stakeholders at BCC. "This research serves as a focal point for their efforts, and we stand united in our hope for future progress in DIPG treatment."

This research grant embodies the tenacity and hope of the DIPG community. We at BCC are thankful for the support offered by all involved, and incredibly grateful for the efforts of the Borkowski, Morissette-Gagne, Ellsworth, Palmowski and Shankar families.

For more information, please contact Brain Cancer Canada or visit www.braincancercanada.ca

Press Contact:
For inquiries, please contact:
Marc Peeters
Director, Partnerships and Stakeholders at Brain Cancer Canada
416-918-6678



These press releases may also interest you

at 05:00
So-Young International Inc. ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its...

at 05:00
OutcomeMD has emerged as a pioneering force, redefining the way patient-reported outcomes (PROs) are utilized in healthcare. Unlike traditional players in the market who focus primarily on aiding physicians with research, OutcomeMD has carved out a...

at 04:35
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) has unveiled a novel approach to stimulate muscle, by way of using brief and mild pulsed electromagnetic...

at 04:05
PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKERtm. The new phenotypic screening platform expands the Company's capabilities in this emerging...

at 04:03
The National Comprehensive Cancer Network® (NCCN®)?a global nonprofit responsible for leading cancer treatment guidelines?is taking part in two events in Warsaw focused on advancing...

at 03:52
The 10th European Stroke Organization Congress (ESOC), held in Basel, Switzerland from May 15 to 17, 2024, showcased six studies on Sanbexin® (Edaravone and Dexborneol Concentrated Solution for Injection) and a new dosage form of sublingual tablets...



News published on and distributed by: